CRM vs PLTR: Which Is the Better Buy?

Side-by-side comparison of Salesforce, Inc. and Palantir Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-08.
Salesforce, Inc. · Technology
$169.52
+45.0% upside to fair value
Grade A High Quality
VS
Palantir Technologies Inc. · Technology
$128.47
-41.4% upside to fair value
Grade C High Quality
QuantHub Verdict
CRM has more upside to fair value (+45.0%). CRM trades at a lower forward P/E (19.6x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric CRM PLTR
Current Price $169.52 $128.47
Fair Value Estimate $245.80 $75.23
Upside to Fair Value +45.0% -41.4%
Market Cap $138.8B $295.0B
Forward P/E 19.6x 133.8x
EV / EBITDA 12.3x 124.7x
Price / Sales 3.2x 56.5x
Price / FCF 9.5x 109.7x
Revenue Growth YoY +13.3% +84.7%
Gross Margin 77.6% 84.1%
Operating Margin 21.9% 38.1%
Return on Equity 14.9% 32.2%
Dividend Yield 0% 0%
FCF Yield 10.56% 0.91%
Analyst Consensus Buy Buy
Investment Thesis
CRM — Salesforce, Inc.
Salesforce, Inc. is a leading provider of cloud-based software applications primarily focused on customer relationship management (CRM). The company exhibits high business quality with a durable competitive moat supported by strong gross margins of 77.6%, solid operating margin of 21.9%, and a robust return on equity of 14.9%. Recent quarterly revenue growth of 13.3% and earnings growth of 36.7% …
PLTR — Palantir Technologies Inc.
Palantir Technologies Inc. is a software infrastructure company specializing in data analytics platforms primarily serving government and commercial clients. The company benefits from a durable competitive moat in government and select commercial verticals, driven by long-tenured founder leadership and high insider ownership. Palantir exhibits very strong recent growth with revenue up approximate…
Accumulation Zones
Metric CRM PLTR
Zone Low $184.35 $56.42
Zone High $208.93 $63.95
In Buy Zone? Yes No
← CRM Research    PLTR Research →    All Research